Skip to main content

Table 4 Health-related quality of life (HRQOL) scores according to physical activity levels among breast cancer survivors with stage II and III breast cancer

From: The association between physical activity and health-related quality of life among breast cancer survivors

HRQOL Items

Physical Activity (MET-hours per week)

All

Tertile 1

Tertile 2

Tertile 3

P for trenda

EORTC QLQ-C30, LS means (95% CI)b

Global health status / QoL

113

48.33 (32.27, 72.39)

31.37 (19.83, 49.61)

43.56 (28.54, 66.49)

0.89

Functioning

 Physical Functioning

128

81.46 (68.05, 97.51)

85.19 (69.31, 104.72)

81.99 (67.23, 99.98)

0.98

 Role Functioning

129

76.34 (53.02, 109.91)

100.65 (65.83, 153.89)

95.71 (64.41, 142.23)

0.36

 Emotional Functioning

130

72.94 (59.76, 89.03)

67.19 (53.42, 84.51)

75.44 (60.73, 93.71)

0.63

 Cognitive Functioning

130

77.05 (59.64, 99.56)

69.47 (51.73, 93.29)

75.00 (56.74, 99.13)

0.96

 Social Functioning

130

59.44 (42.46, 83.22)

78.02 (52.98, 114.91)

70.92 (49.17, 102.29)

0.49

Symptom

 Fatigue

129

18.19 (12.29, 26.91)

19.25 (12.25, 30.25)

11.47 (7.43, 17.71)

0.02

 Nausea / Vomiting

130

2.53 (1.38, 4.63)

2.20 (1.09, 4.41)

2.17 (1.12, 4.19)

0.69

 Pain

129

11.40 (5.74, 22.67)

7.32 (3.32, 16.17)

6.15 (2.87, 13.17)

0.14

 Dyspnea

129

5.29 (2.60, 10.74)

2.90 (1.28, 6.57)

3.93 (1.79, 8.61)

0.63

 Insomnia

128

12.16 (6.05, 24.45)

19.57 (8.75, 43.75)

12.05 (5.56, 26.12)

0.78

 Appetite loss

128

2.28 (1.25, 4.15)

3.06 (1.53, 6.09)

2.11 (1.09, 4.10)

0.67

 Constipation

128

3.90 (1.87, 8.15)

3.56 (1.53, 8.27)

1.93 (0.86, 4.34)

0.08

 Diarrhea

130

2.72 (1.36, 5.45)

2.11 (0.95, 4.69)

3.51 (1.65, 7.46)

0.40

 Financial Problems

130

5.33 (2.56, 11.10)

8.65 (3.72, 20.11)

4.30 (1.94, 9.56)

0.42

EORTC QLQ-BR23, LS means (95% CI)b

Functioning

 Body image

130

26.17 (14.74, 46.48)

24.74 (12.78, 47.91)

22.67 (12.13, 42.35)

0.66

 Sexual functioning

115

1.97 (1.00, 3.85)

1.61 (0.76, 3.41)

5.77 (2.92, 11.39)

0.001

 Sexual enjoyment

36

10.24 (1.60, 65.60)

3.36 (0.64, 17.61)

7.46 (1.29, 43.12)

0.97

 Future perspective

130

16.23 (8.49, 31.02)

12.63 (5.99, 26.62)

15.43 (7.62, 31.23)

>0.99

Symptom

 Systematic therapy side effects

130

23.04 (16.92, 31.36)

30.31 (21.25, 43.22)

23.11 (16.52, 32.33)

0.75

 Breast symptoms

130

16.84 (9.26, 30.60)

11.09 (5.58, 22.06)

14.16 (7.39, 27.13)

0.77

 Arm symptoms

130

19.83 (11.69, 33.65)

26.64 (14.50, 48.95)

22.71 (12.77, 40.37)

0.78

 Upset by hair loss

88

19.92 (7.97, 49.81)

26.82 (9.60, 74.98)

22.28 (8.72, 56.92)

0.89

  1. MET metabolic equivalent, EORTC QLQ-C30 European organization for research and treatment of cancer quality of life questionnaire core 30, LS least-squares, CI confidence interval, EORTC QLQ-BR23 European organization for research and treatment of cancer quality of life questionnaire breast cancer module 23
  2. aP for trend was calculated using the median value of each tertile category as a continuous variable
  3. bAdjusted for age (year: continuous), energy intake (kcal/day: continuous), dietary supplement use (yes, no), education level (high school or less, college or more), marital status (married or cohabitated, unmarried or divorced or widowed), time since surgery (6 month – 1 year, 1 year - 5 years, ≥ 5 years), stage (II or III), and center
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us